SARS-CoV-2 Seroprevalence in Vancouver District Schools
Speakers: P Lavoie, D Goldfarb
Dr. Pascal Lavoie, Neonatologist, BC Women’s Hospital, Associate Professor, Department of Pediatrics, University of British Columbia, BC Children’s Hospital & Women’s Health Research Institute
Dr. David Goldfarb, Investigator and Medical Microbiologist, BC Children’s Hospital, Clinical Associate Professor, Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia
Drs. Lavoie and Goldfarb’s core research focuses on the developing immune system in early life. However, with the pandemic, a major focus in their research was re-oriented towards understanding immunity to SARS-CoV-2 at the population level, as well as on two COVID‑19 Immunity Task Force-funded studies on the 1) impact of pre-existing immunity on SARS-CoV-2 vaccine responses, and 2) SARS-CoV-2 infections within schools. Join us as Drs. Pascal Lavoie and David Goldfarb present key findings on this timely work during the pandemic.
Related Resources
Event
February 9, 2021
SARS-CoV-2 Variants: Clinical, Vaccine and Public Health Implications
Speaker: C Kaushic
Event
July 27, 2021
A Guide to Vaccine Hesitancy Conversations: Building Confidence in Primary Care
Speakers: M Leslie, R Fadaak, N Pinto
Event
June 1, 2021
Evidence-Based Debunking: Needed and Effective
Speaker: T Caulfield
Event
April 27, 2021
CoVaRR Net – Canada’s latest research network on the pandemic response
Speaker: M Langlois
